Identification and validation of a threshold for early posttransplant bronchoalveolar fluid hyaluronan that distinguishes lung recipients at risk for chronic lung allograft dysfunction

被引:0
|
作者
Todd, Jamie L. [1 ,2 ]
Weber, Jeremy M. [2 ]
Kelly, Francine L. [1 ]
Nagler, Andrew [1 ]
Mcarthur, Patrick
Eason, Lerin [1 ]
Rim, Jeeyon G. [1 ]
Frankel, Courtney W. [1 ]
Belperio, John A. [3 ]
Budev, Marie [4 ]
Martinu, Tereza [5 ,6 ,7 ]
Patel, Kunal [8 ]
Reynolds, John M. [1 ]
Shah, Pali D. [9 ]
Singer, Lianne G. [5 ,6 ,7 ]
Snyder, Laurie D. [1 ,2 ]
Tsuang, Wayne [4 ]
Weigt, S. Sam [3 ]
Neely, Megan L. [2 ,10 ]
Palmer, Scott M. [1 ,2 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC USA
[2] Duke Clin Res Inst, Durham, NC USA
[3] Univ Calif Los Angeles, Dept Med, Los Angeles, CA USA
[4] Cleveland Clin, Dept Med, Cleveland, OH USA
[5] Univ Hlth Network, Dept Med, Toronto, ON, Canada
[6] Univ Toronto, Dept Med, Toronto, ON, Canada
[7] Univ Hlth Network, Ajmera Transplant Ctr, Toronto Lung Transplant Program, Toronto, ON, Canada
[8] Duke Univ, Med Ctr, Dept Surg, Durham, NC USA
[9] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
[10] Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC USA
来源
基金
美国国家卫生研究院;
关键词
lung transplantation; chronic lung allograft dysfunction; hyaluronan; bronchoalveolar lavage fluid;
D O I
10.1016/j.healun.2024.10.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Few tools exist for the early identification of patients at risk for chronic lung allograft dysfunction (CLAD). We previously showed hyaluronan (HA), a matrix molecule that regulates lung inflammation and fibrosis, accumulates in bronchoalveolar lavage fluid (BALF) and blood in CLAD. We aimed to determine if early posttransplant HA elevations inform CLAD risk. METHODS: HA was quantified in 3,080 BALF and 1,323 blood samples collected over the first posttransplant year in 743 adult lung recipients at 5 centers. The relationship between BALF or blood HA and CLAD was assessed using Cox models with a time-dependent binary covariate for "elevated" HA. Potential thresholds for elevated HA were examined using a grid search between the 50th and 85th percentile. The optimal threshold was identified using fit statistics, and the association between the selected threshold and CLAD was internally validated through iterative resampling. A multivariable Cox model using the selected threshold was performed to evaluate the association of elevated HA with CLAD, considering other factors that may influence CLAD risk. RESULTS: BALF HA levels > 19.1 ng/ml (65th percentile) had the largest hazard ratio (HR) for CLAD (HR 1.70, 95% confidence interval [CI] 1.25-1.31; p < 0.001), optimized fit statistics, and demonstrated robust reproducibility. In a multivariable model, the occurrence of BALF HA > 19.1 ng/ml in the first posttransplant year conferred a 66% increase in the hazards for CLAD (adjusted HR 1.66, 95% CI 1.19-2.32; p = 0.003). Blood HA was not significantly associated with CLAD. CONCLUSIONS: We identified and validated a precise threshold for BALF HA in the first post- transplant year that distinguishes patients at increased CLAD risk. J Heart Lung Transplant 2025;44:320-328 (c) 2024 International Society for Heart and Lung Transplantation. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:320 / 328
页数:9
相关论文
共 50 条
  • [41] Prognostic Significance of Mesenchymal Cell Colony Forming Units in Bronchoalveolar Lavage Fluid for Restrictive Chronic Lung Allograft Dysfunction
    Combs, M. P.
    Xia, M.
    Wheeler, D. S.
    Belloli, E. A.
    Lyu, D. M.
    Walker, N. M.
    Murray, S.
    Lama, V. N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S29 - S29
  • [42] Surrogate markers and risk factors for chronic lung allograft dysfunction
    Bowdish, ME
    Arcasoy, SM
    Wilt, JS
    Conte, JV
    Davis, RD
    Garrity, ER
    Hertz, ML
    Orens, JB
    Rosengard, BR
    Barr, ML
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (07) : 1171 - 1178
  • [43] Pseudomonas and risk factor mitigation for chronic lung allograft dysfunction
    Glanville, Allan R.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (04)
  • [44] Early experience with sirolimus in lung transplant recipients with chronic allograft rejection
    Cahill, BC
    Somerville, KT
    Crompton, JA
    Parker, ST
    O'Rourke, MK
    Stringham, JC
    Karwande, SV
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2003, 22 (02): : 169 - 176
  • [45] Distress and alexithymia in lung recipients - psychosocial strains and associations with chronic allograft dysfunction
    Goetzmann, Lutz
    Irani, Sarosh
    Schwegler, Kyrill
    Stamm, Martina
    Bricman, Rosemarie
    Baddeberg, Claus
    Schmid, Christoph
    Benden, Christian
    Klaghofer, Richard
    Boehler, Annette
    SWISS MEDICAL WEEKLY, 2010, 140 (25-26) : 382 - 387
  • [46] Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection
    Bharat, Ankit
    Narayanan, Kishore
    Street, Tyler
    Fields, Ryan C.
    Steward, Nancy
    Aloush, Aviva
    Meyers, Brian
    Schuessler, Richard
    Trulock, Elbert P.
    Patterson, G. Alexander
    Mohanakumar, Thalachallour
    TRANSPLANTATION, 2007, 83 (02) : 150 - 158
  • [47] Interstitial Pneumonitis and the Risk of Chronic Allograft Rejection in Lung Transplant Recipients
    Mihalek, Andrew D.
    Rosas, Ivan O.
    Padera, Robert E., Jr.
    Fuhlbrigge, Anne L.
    Hunninghake, Gary M.
    DeMeo, Dawn L.
    Camp, Phillip C., Jr.
    Goldberg, Hilary J.
    CHEST, 2013, 143 (05) : 1430 - 1435
  • [48] Risk factors for chronic renal dysfunction in lung transplant recipients
    Esposito, Ciro
    De Mauri, Andreana
    Vitulo, Patrizio
    Oggionni, Tiberio
    Cornacchia, Flavia
    Valentino, Rossella
    Grosjean, Fabrizio
    Torreggiani, Massimo
    Dal Canton, Antonio
    TRANSPLANTATION, 2007, 84 (12) : 1701 - 1703
  • [49] Complement (C3a) Levels are Increased in the Bronchoalveolar Lavage Fluid of Patient with All Chronic Lung Allograft Dysfunction Phenotypes
    Combs, M. P.
    Vittal, R.
    Wheeler, D. S.
    Walker, N. M.
    Lama, V. N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S252 - S252
  • [50] Spectral and Intrabreath Oscillometry for Early Diagnosis of Chronic Lung Allograft Dysfunction
    Fu, A.
    Vasileva, A.
    Hanafi, N.
    Rajyam, S.
    Tanumihardja, G.
    Belousova, N.
    Wu, J.
    Huszti, E.
    Hantos, Z.
    Chow, C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S332 - S332